- Treatment of potentially resectable malignancies of the pancreatic head, the papilla, and the distal bile duct.
Rare indications: Duodenal carcinomas, benign or cystic tumors, chronic pancreatitis, or so-called "dilemma" cases (when imaging and clinical presentation cannot reliably differentiate between inflammatory and malignant pancreatic head tumors).
In principle, the indication for pancreatic head resection exists in cases of malignancies or sufficient suspicion of malignancy whenever there is at least the prospect of resecting the tumor in toto pre- and intraoperatively, and the patient is in a general condition adequate for this procedure.
- The indication for resection should be made promptly by the surgeon, especially in potentially resectable findings in jaundiced patients. Only in patients with manifest secondary complications of jaundice (decompensated plasma coagulation, liver synthesis disorder, reduced cellular defense, purulent cholangitis) should preoperative endoscopic bile duct drainage be considered to gain time and create a better starting situation for the operation. In all other cases, preoperatively placed bile duct drainage, whether TPCD (transpapillary) or PTCD (percutaneous-transhepatic), should be avoided due to increased postoperative morbidity.
In the case of infiltration of large veins (superior mesenteric vein, splenic vein, or portal vein), resection should be pursued, if necessary with vascular reconstruction, as preoperative diagnostics often cannot differentiate between inflammatory adhesion and tumor infiltration.
Comorbidity is another essential factor in determining the indication. Patients with severe cardiovascular comorbidities carry a significantly increased surgical risk; however, advanced age in itself is no longer a contraindication for pancreatic head resection today.